CDC and FDA recommend US pause use of Johnson & Johnson’s Covid-19 vaccine over blood clot concerns

By Elizabeth Cohen and Jacqueline Howard | CNN

The US Centers for Disease Control and Prevention and the US Food and Drug Administration are recommending that the United States pause the use of Johnson & Johnson’s Covid-19 vaccine over six reported US cases of a “rare and severe” type of blood clot.

The six reported cases were among more than 6.8 million doses of the Johnson & Johnson vaccine administered in the United States.

All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination, according to a joint statement on Tuesday from Dr. Anne Schuchat, principal deputy director

→ Continue reading at Silicon Valley

More from author

Related posts

Advertisment

Latest posts

PG&E Admits it Broke 2020 Promise to Fully Inspect 50K Poles in High Fire Risk Zones

INVESTIGATIVE PG&E Admits it Broke 2020 Promise to Fully Inspect 50K...

AI (Artificial Intelligence): How Non-Tech Firms Can Benefit

Even though AI continues to thrive and grow, there remain challenges to use the technology. Just some include finding data scientists, determining the right...

Solana, a blockchain platform followed by top crypto investors, says it’s far faster than Ethereum

Solana isn’t widely known yet outside of the crypto community. But insiders think the blockchain platform is interesting for a wide variety of reasons,...